Literature DB >> 9415416

8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity.

M Roederer1, S De Rosa, R Gerstein, M Anderson, M Bigos, R Stovel, T Nozaki, D Parks, L Herzenberg, L Herzenberg.   

Abstract

We developed the chemistry, instrumentation, and software technologies needed to measure, simultaneously and independently, eight different fluorescent molecules on individual cells. Conjugation of these fluorochromes to monoclonal antibodies is straightforward; all immunofluorescence staining is accomplished with direct stains only. We built a hybrid flow cytometer with eight fluorescence detectors and two light scatter channels, with excitation provided by three spatially separated laser beams emitting at 407 nm, 488 nm, and 595 nm. The fluorescence compensation required to make the data orthogonal is of sufficient complexity that it cannot be performed manually; thus, we use software to compensate the data post hoc, based on data collected from singly stained compensation control samples. In this report, we evaluate the 8 color staining technology. Of the seven fluorochromes other than fluorescein, six have a useful brightness at least as great as fluorescein. Three of the fluorochromes (phycoerythrin, allophycocyanin, and the Cy5 resonance energy tandem of phycoerythrin) are considerably brighter than fluorescein and are useful for detecting antigens expressed at low levels. Finally, we show the power and utility of the 8 color, 10-parameter technology using staining experiments on both human and murine immune systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415416     DOI: 10.1002/(sici)1097-0320(19971201)29:4<328::aid-cyto10>3.0.co;2-w

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  26 in total

1.  A novel sensitive microarray approach for differential screening using probes labelled with two different radioelements.

Authors:  H Salin; T Vujasinovic; A Mazurie; S Maitrejean; C Menini; J Mallet; S Dumas
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry.

Authors:  Christina Basford; Nico Forraz; Colin McGuckin
Journal:  Nat Protoc       Date:  2010-06-24       Impact factor: 13.491

Review 3.  A chromatic explosion: the development and future of multiparameter flow cytometry.

Authors:  Pratip K Chattopadhyay; Carl-Magnus Hogerkorp; Mario Roederer
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

4.  Cytometric sorting based on the fluorescence lifetime of spectrally overlapping signals.

Authors:  Ruofan Cao; Varayini Pankayatselvan; Jessica P Houston
Journal:  Opt Express       Date:  2013-06-17       Impact factor: 3.894

5.  Next-generation flow cytometry.

Authors:  Matthew R Janes; Christian Rommel
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

6.  Advantages of full spectrum flow cytometry.

Authors:  Claire K Sanders; Judith R Mourant
Journal:  J Biomed Opt       Date:  2013-03       Impact factor: 3.170

Review 7.  A deep profiler's guide to cytometry.

Authors:  Sean C Bendall; Garry P Nolan; Mario Roederer; Pratip K Chattopadhyay
Journal:  Trends Immunol       Date:  2012-04-02       Impact factor: 16.687

Review 8.  New approaches for the detection of minimal residual disease in acute myeloid leukemia.

Authors:  Anna van Rhenen; Bijan Moshaver; Gert J Ossenkoppele; Gerrit Jan Schuurhuis
Journal:  Curr Hematol Malig Rep       Date:  2007-05       Impact factor: 3.952

9.  Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites.

Authors:  K J Seidl; J A Wilshire; J D MacKenzie; A B Kantor; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

10.  Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.

Authors:  Rebecca L Matz; Blake Erickson; Sriram Vaidyanathan; Jolanta F Kukowska-Latallo; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.